Apogee Therapeutics CEO Michael Henderson sells $2.67m in stock
investment News
Apogee Therapeutics CEO Michael Henderson sells $2.67m in stock
Apogee Therapeutics CEO Michael Henderson sells $2.67m in stock investment News
Continue Reading
Related market coverage
News
U.S. Stock Market Ticks Higher With Memory Chip Maker’s Big Debut
U.S. stocks were slightly higher after a multibillion-dollar share offering in the semiconductor sector steadied volatility. The Dow Jones Industrial Average rose…
News
‘Day-to-day dread’ haunts frustrated job seekers in era of low hiring
‘Day-to-day dread’ haunts frustrated job seekers in era of low hiring Invest Market Updates N/A,Labor/Personnel Issues,Corporate/Industrial News,Recruitment,Lay-offs/Redundancies,Workers Pay,Economic Performance/Indicators,Employment/Unemployment Figures,Economic News,Artificial Intelligence/Machine…
News
Strategy $216M Bitcoin Sale May Boost Price, Says Grayscale — How High?
Key Takeaways Strategy sold 3,588 Bitcoin worth $216 million to fund preferred security dividends. Grayscale says the sale could be bullish for…